IFNA1 and ovarian cancer: Increased induction of IFN/ISGs by T3DTD was further confirmed in ID8 murine ovarian cancer cells, and in the B16-F10 murine melanoma system where T3DPL was previously characterized to exert more oncolytic activity in vivo relative to T3DTD (S1D and S1E Fig).